lbct dapagliflozin and atrial fibrillation in hfpef in deliver | esc congress 2022
Published 2 years ago • 897 plays • Length 2:28Download video MP4
Download video MP3
Similar videos
-
2:52
lbct recent hf hospitalization in deliver | esc congress 2022
-
3:35
teer for atrial secondary mr | esc congress 2022
-
6:27
pardeep jhund, esc 2022: dapagliflozin for heart failure, pooled analysis of dapa-hf and deliver
-
15:02
day 2 highlights | esc congress 2022
-
2:42
sacubitril/valsartan and frailty in hfpef in paragon-hf | esc congress 2022
-
2:15
unveiling cardiac amyloidosis | esc congress 2022
-
2:53
dapagliflozin for heart failure: a pooled analysis of dapa-hf and deliver
-
10:07
day 1 highlights | esc congress 2022
-
1:10:40
acc cardiology hour from esc congress 2022
-
11:28
esc 2022 late-breaker discussion: the deliver trial
-
8:03
day 4 highlights | esc congress 2022
-
8:41
delivering the details on dapagliflozin in heart failure
-
21:12
updates from the step-hfpef trial | esc 2024
-
1:46
supraventricular arrhythmia following pfo closure | esc congress 2022
-
2:16
esc tv at #esccongress 2022 - deliver and emperor-preserved
-
3:35
hf 2022: deliver extends benefits of dapagliflozin to the full spectrum of pts with hf
-
2:07
esc tv at #esccongress 2022 - dapa-hf and deliver